IRIS
PASTA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.059
AS - Asia 903
NA - Nord America 578
SA - Sud America 90
AF - Africa 19
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.652
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.863
US - Stati Uniti d'America 551
SG - Singapore 350
CN - Cina 276
VN - Vietnam 174
FR - Francia 60
BR - Brasile 56
FI - Finlandia 39
HK - Hong Kong 31
DE - Germania 25
AR - Argentina 22
GB - Regno Unito 20
BD - Bangladesh 13
CA - Canada 13
MX - Messico 12
JP - Giappone 9
ID - Indonesia 8
IE - Irlanda 7
IN - India 7
NL - Olanda 7
UA - Ucraina 6
PH - Filippine 5
PL - Polonia 5
EG - Egitto 4
ES - Italia 4
IQ - Iraq 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AT - Austria 3
EC - Ecuador 3
MY - Malesia 3
RU - Federazione Russa 3
SE - Svezia 3
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
KE - Kenya 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PK - Pakistan 2
SA - Arabia Saudita 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.652
Salva come PNG Salva come JPEG
Città #
Genoa 1.988
Vado Ligure 411
Genova 224
San Jose 147
Singapore 147
Rapallo 114
Ashburn 93
Council Bluffs 66
Lauterbourg 54
Hanoi 48
Beijing 44
Ho Chi Minh City 44
New York 43
Hong Kong 29
Chicago 21
Frankfurt am Main 21
Helsinki 21
Lappeenranta 18
Rome 17
Santa Clara 17
Los Angeles 16
Milan 16
Orem 13
Mexico City 10
St Louis 10
Tianjin 10
Turin 10
Haiphong 9
Tokyo 9
Camaiore 8
Da Nang 8
Dublin 7
Bordighera 6
Atlanta 5
Dallas 5
Montreal 5
Naples 5
Salt Lake City 5
Toronto 5
Warsaw 5
Bologna 4
Can Tho 4
Guangzhou 4
Kyiv 4
Manchester 4
São Paulo 4
Tampa 4
Tashkent 4
Biên Hòa 3
Buenos Aires 3
Cairo 3
Cardiff 3
Hải Dương 3
Marseille 3
Poplar 3
Stockholm 3
Addis Ababa 2
Amsterdam 2
Baghdad 2
Brooklyn 2
Brugherio 2
Buffalo 2
Catania 2
Chennai 2
City of London 2
Des Moines 2
Duque de Caxias 2
Elk Grove Village 2
Gresham 2
Johannesburg 2
Kuala Lumpur 2
London 2
Lấp Vò 2
Madrid 2
Messina 2
Milwaukee 2
Nairobi 2
Ninh Bình 2
Philadelphia 2
Prague 2
Quảng Ngãi 2
Rio de Janeiro 2
Shanghai 2
São José dos Campos 2
Tân Tiến 2
Vienna 2
Zurich 2
Abidjan 1
Acalanes Ridge 1
Algiers 1
Antalya 1
Artur Nogueira 1
Atibaia 1
Baku 1
Baltimore 1
Bandung 1
Banfield 1
Bang Lamung 1
Bari 1
Barranquilla 1
Totale 3.865
Salva come PNG Salva come JPEG
Nome #
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 135
PCSK9 inhibitors for treating hypercholesterolemia 129
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 127
Diet and nutraceutical supplementation in dyslipidemic patients: First results of an italian single center real‐world retrospective analysis 124
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 114
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 113
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies 111
Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis 101
Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol 99
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 99
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study 92
Esophageal motor disorders across ages: A retrospective multicentric analysis 88
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 82
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation? 79
Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD) 79
Albumin-bilirubin score in non-malignant liver diseases should be properly validated 79
Evaluation of the pathophysiological association between the GERD and OSAS: Esophageal pH-monitoring results beyond Lyon criteria 78
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 78
Food Intolerances, Food Allergies and IBS: Lights and Shadows 76
Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study 76
Clopidogrel-Induced Eosinophilic Colitis 75
Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high‐resolution manometry studies 75
Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection 74
The crohn's disease exclusion diet in adults with mild-to-moderate crohn’s disease activity: A real-world open-label randomized controlled trial 74
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 74
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease 73
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 72
Endoscopic Management of Eosinophilic Esophagitis: A Narrative Review on Diagnosis and Treatment 70
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma 69
Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adults 68
Second‐Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta‐Analysis 67
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia 67
Biliary reflux after bariatric surgery and after gastroesophageal surgery for gastroesophageal reflux disease 66
Assessing the short-term prognosis of patients with cirrhosis using the DIC scores 66
Whey proteins inhibit food intake and tend to improve oxidative balance in obese zucker rats 66
Role of dietary intervention in patients with metabolic syndrome and {NAFLD}-{NASH} 65
Diagnostic delay in achalasia 65
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 60
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 59
Changing epidemiology of hepatocellular carcinoma in the Mediterranean area: a challenge for surveillance? 58
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission 57
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) 57
SAFETY AND EFFICACY OF ATEZOLIZUMAB/ BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND IMPAIRED LIVER FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS 56
Distribution of esophageal inflammation in patients with eosinophilic esophagitis and its impact on diagnosis and outcome 55
Hepatocellular carcinoma in patients with Autoimmune Hepatitis 55
Evaluation of adherence to Mediterranean diet, assessed by a food frequency questionnaire, in dyslipidemic patients and evaluation of dietary intervention efficacy 54
Exploring new noninvasive parameters to predict oesophageal varices in patients with NAFLD-associated compensated liver cirrhosis 53
Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta-analysis 53
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial 52
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply' 51
Surveillance for hepatocellular carcinoma in patients with Primary Biliary Cholangitis: for all or just for some? 51
Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration 50
The levels of lipoprotein (a) in the modulation of carotid atherosclerosis risk in a group of patients with metabolic syndrome in primary prevention 49
Role of prokinetics in ineffective esophageal motility: A call for broader consideration and future innovations 45
CLINICAL AND ENDOSCOPIC-HISTOLOGICAL FEATURES OF MULTIFOCAL AND CORPUS-RESTRICTED ATROPHIC GASTRITIS PATIENTS WITH NON-CARDIA GASTRIC CANCER OR DYSPLASIA: A MULTICENTER, CROSS-SECTIONAL STUDY 44
Is global score better than a single histological parameter for assessing microscopic esophagitis? 42
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 42
Decline in LDL-C control in patients with dyslipidemia treated with PCSK9-inhibitors: The role of obesity in LDL-C target achievement 42
Autoimmune Hepatitis-Associated Hepatocellular Carcinoma: Clarifying the Evidence-A Reply 39
Diet in Inflammatory Bowel Diseases: Efficacy, Tolerability, and Microbiome Effects Toward Personalized Management 38
Eosinophilic esophagitis is the leading cause of dysphagia in an outpatient setting 37
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 35
Immune checkpoint inhibitors in malignancies after liver transplantation: a systematic review and pooled analysis 35
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 33
Prevalence of Dysphagia and Its Health Implications Among Elderly Residents in Long-Term Care Facilities in the Liguria Region (Italy): An Observational Cohort Study 32
Updated treatment options for gastroesophageal reflux disease in children: practical guide for clinician 32
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysis 31
null 30
Diet and Nutraceutical Supplementation in Dyslipidemic Patients: First Results of an Italian Single Center Real-World Retrospective Analysis 30
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 27
Resolution of Hepatitis Delta Virus-related Cryoglobulinemic Vasculitis with the Use of Bulevirtide: a Case Report 24
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 21
Dietary and Nutraceutical Interventions for Functional Dyspepsia: A Narrative Review 19
Health inequalities in patients with cirrhosis: investigating the impact of material deprivation on patients’ outcomes. 19
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 17
The promise and pitfalls of Emerging Potassium-Competitive Acid Blockers for the treatment of Gastroesophageal reflux disease 17
The Therapeutic Pipeline for Eosinophilic Esophagitis: Current Landscape and Future Directions 17
Abnormal Milan Score and Compromised Esophageal Mucosal Integrity Stratify Gastroesophageal Reflux Disease Severity 17
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes 16
Optimizing bracnh-duct intraductal papillary mucinous neoplasms surveillance: data-driven dimensional grouping for risk stratification and cost-effectiveness. The PACMANS Study 16
Sustained Virologic Response and Prognosis in HCV-related Hepatocellular Carcinoma: Lessons from Complementary Cohorts 15
Evaluation of the diagnostic accuracy of two esophageal biopsy sites compared to three in histological follow-up of eosinophilic esophagitis – A multicentric study 14
Assessment of Esophagogastric Junction Barrier Function With the Supine‐Upright Transition of the Chicago Classification Protocol 14
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 12
Combined Lyon and Milan Scores Predict Gerd Management Outcome Better Than Either Score Alone or Their Individual Components 12
Corrigendum to “Esophageal motility disorders among elderly patients: An international multicenter study” [Digestive and Liver Disease 57 (2025) 1615-1621] 10
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study 10
Comparative efficacy of initial treatment strategies in patients with TACE-unsuitable hepatocellular carcinoma 9
It takes two to tango: Preserving liver function competes with response to systemic therapy in patients with HCC and decompensated cirrhosis 6
Recurrent hepatic encephalopathy after abdominal surgery in a non-cirrhotic patient: a case report. 6
Mean Nocturnal Baseline Impedance in Gastroesophageal Reflux Disease: Considerations on the Study by Lee et al 6
The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric Junction 5
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 4
Esophageal motility disorders among elderly patients: An international multicenter study 4
Research gaps in eosinophilic esophagitis: unanswered questions and future directions 1
Esophageal Function Testing Identifies Barrett’s Esophagus Patients With Pathological Acid Exposure at Risk for Neoplasia 1
Totale 4.941
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.796
article - articoli 16.796
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 9 3 2
2021/2022125 7 0 0 4 15 12 0 29 21 13 5 19
2022/2023150 17 19 3 5 22 19 13 11 19 1 17 4
2023/2024275 9 21 2 32 15 31 23 14 22 21 28 57
2024/20251.253 59 53 50 91 136 111 111 231 52 41 170 148
2025/20263.022 296 98 349 336 405 211 390 194 336 407 0 0
Totale 4.941